Nevertheless, consistent with the conclusion drawn by Shigaki H et al. [55], in another study involving in silico analyses of 104 Chinese patients who underwent next-generation sequencing [85], the authors showed that PIK3CA mutation was associated with longer overall survival in patients with ESCC. This evidence concerns the gene PIK3CA and esophageal squamous cell carcinoma.